MMRSNMersana Therapeutics Inc

Mersana Therapeutics Inc

MRSN

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive MRSN chart

  • Mkt cap

    $145.36M

  • EV/Sales

    1.51

  • P/E ratio

    N/A

  • FY2024 Revenue

    $40.50M

  • EPS (9mo ended 2025-09-30)

    $-11.00

  • Gross Margin (FY2024)

    N/A

  • Profit Margin (FY2024)

    -170.86%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live MRSN terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

MRSN — Mersana Therapeutics Inc · rev $40.5M

MRSN Key Statistics

  • Market Cap: $145.4M
  • P/B Ratio: 32.0

Mersana Therapeutics Inc latest statements (FY2024)

Latest cached year on this hub. Full MRSN income, balance, and cash tables.

  • Revenue$40.5M
  • Net Income-$69.2M
  • Total Assets$144.7M
  • Total Debt$23.4M
  • Free Cash Flow-$82.5M

† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).

MRSN FAQ

What industry is MRSN in?

Mersana Therapeutics Inc (MRSN) is a biotechnology company in the Healthcare sector.

What are MRSN's latest revenue and net income?

Latest cached Mersana Therapeutics Inc (MRSN) revenue for Dec 31, 2024 was $40.5M. Net income was -$69.2M. Statements: https://lician.com/financials/mrsn

What is MRSN's market cap?

Mersana Therapeutics Inc (MRSN) market capitalization is $145.4M on the latest cached snapshot.

Live MRSN terminal loads when you scroll near this section.